Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging-Reference-Cited by-同舟云学术

Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging

Published:2021-07-01 Issue:4 Volume:28 Page:1769-1774
ISSN:1071-3581
Container-title:Journal of Nuclear Cardiology
language:en
Short-container-title:J. Nucl. Cardiol.

Author:

Dorbala Sharmila,Ando Yukio,Bokhari Sabahat,Dispenzieri Angela,Falk Rodney H.,Ferrari Victor A.,Fontana Marianna,Gheysens Olivier,Gillmore Julian D.,Glaudemans Andor W. J. M.,Hanna Mazen A.,Hazenberg Bouke P. C.,Kristen Arnt V.,Kwong Raymond Y.,Maurer Mathew S.,Merlini Giampaolo,Miller Edward J.,Moon James C.,Murthy Venkatesh L.,Quarta C. Cristina,Rapezzi Claudio,Ruberg Frederick L.,Shah Sanjiv J.,Slart Riemer H. J. A.,Verberne Hein J.,Bourque Jamieson M.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s12350-020-02455-z.pdf

Reference5 articles.

1. Sperry BW, Burgett E, Bybee KA, McGhie AI, O’Keefe JH, Saeed IM, et al. Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: Imaging at 1 vs 3 hours and planar vs SPECT/CT. J Nucl Cardiol 2020;27(5):1802–7. https://doi.org/10.1007/s12350-020-02139-8.

2. Masri A, Bukhari S, Ahmad S, Nieves R, Eisele YS, Follansbee W, et al. Efficient 1-hour Technetium-99m pyrophosphate imaging protocol for the diagnosis of Transthyretin Cardiac Amyloidosis. Circ Cardiovasc Imaging 2020;13:e010249. https://doi.org/10.1161/CIRCIMAGING.119.010249.

3. Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, et al. Multicenter study of planar Technetium 99m pyrophosphate cardiac imaging: Predicting survival for patients With ATTR Cardiac Amyloidosis. JAMA Cardiol 2016;1(8):880–9. https://doi.org/10.1001/jamacardio.2016.2839.

4. Tamarappoo B, Otaki Y, Manabe O, Hyun M, Cantu S, Arnson Y, et al. Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis. J Nucl Cardiol 2020;27:28–37.

5. Manrique A, Dudoignon D, Brun S, N’Ganoa C, Cassol E, Legallois D, et al. Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis. EJNMMI Res 2019;9:117.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diflunisal versus tafamidis on neuropathy and cardiomyopathy in hereditary transthyretin amyloidosis;Annals of Clinical and Translational Neurology;2024-08-02

2. Evolution of cardiac amyloidosis imaging with bone-avid tracers: From qualification to quantification;Journal of Nuclear Cardiology;2024-08

3. Bilateral Multiple Fractures Obstruct Quantitation of 99mTc-Pyrophosphate Imaging for Cardiac Amyloidosis;Clinical Nuclear Medicine;2024-04-19

4. 2024 Australia–New Zealand Expert Consensus Statement on Cardiac Amyloidosis;Heart, Lung and Circulation;2024-04

5. Procedure Guideline for Scintigraphic Imaging in Cardiac Transthyretin Amyloidosis;Nuclear Medicine Seminars;2024-04-01